Stock listing

Photocure Asa

Selected listing: PHS · DUS · EUR · DE

Photocure Asa (Dusseldorf:PHS), Health Technology. Latest release Aug 17, 2026: Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light…

PHS:DUSEURDEUpdated October 3, 2026

Ticker: Dusseldorf:PHS
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Dusseldorf
Currency: EUR

About Photocure Asa

The company specializes in developing and commercializing innovative products for the diagnosis and treatment of cancer. Photocure's focus is on enhancing patient outcomes through its advanced medical technologies.

Latest news from Photocure Asa

Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

August 17, 2026

Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

August 11, 2026

Photocure ASA - Share option grant to members of the board of directors

August 7, 2026

Photocure ASA: Results for the second quarter of 2026

July 29, 2026

Photocure : initiates arbitration in partial milestone payment case with Asieris Pharmaceuticals

July 23, 2026

All Photocure Asa news →

Events

Replays

Photocure ASA (0IMT) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:00 AM ET
Watch
Photocure ASA (0IMT) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:00 AM ET
Watch
Photocure ASA (0IMT) Q4 2025 Earnings Call
Wed, Feb 18, 2026 · 08:00 AM ET
Watch

Research Photocure Asa

Photocure Asa company profile

View the public company page for Photocure Asa on 6ix.

Photocure Asa news

Read company news and market updates connected to Photocure Asa.

Photocure Asa investor events

Find investor webinars, events, and replay context for Photocure Asa.